Biorithm, a Singapore-based global women's medical technology company involved in developing solutions for personalised connected maternity care, including Femom, a comprehensive remote obstetric monitoring system, announced on Monday that it has named Jenny Hoffmann, PhD as its new CEO.

Dr Hoffmann has served for 13 years in executive positions at WL Gore & Associates, including business leadership for various medical devices. She holds a Bachelor of Science degree in Engineering and Applied Science from the University of Virginia. She has completed her PhD in Bioengineering from Rice University.

Amrish Nair, founder, CTO and chairman of the Biorithm board, said, 'Dr Hoffmann is a visionary executive with a history of development and commercialisation of medical devices that improve patients' lives. On behalf of the Biorithm board, I welcome Dr Hoffmann and look forward to her leadership in bringing Biorithm's vision to life for clinicians and patients around the world.'